Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection
- PMID: 21123537
- PMCID: PMC3043497
- DOI: 10.1128/JCM.01028-10
Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection
Abstract
We compared two commercial PCR assays, the Prodesse ProGastro CD assay and the BD GeneOhm Cdiff assay, with a laboratory-developed Clostridium difficile toxin PCR assay with previously established performance characteristics. Results of all methods were in agreement for 333 (96%) of 346 stool specimens. No significant difference in performance among the assays was found (P values, >0.05).
References
-
- Aldeen W. E., et al. 2000. Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools. Diagn. Microbiol. Infect. Dis. 36:211–213 - PubMed
-
- Arzese A., Trani G., Riul L., Botta G. A. 1995. Rapid polymerase chain reaction method for specific detection of toxigenic Clostridium difficile. Eur. J. Clin. Microbiol. Infect. Dis. 14:716–719 - PubMed
-
- Bartlett J. G. 2002. Clinical practice: antibiotic-associated diarrhea. N. Engl. J. Med. 346:334–339 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
